Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Solifenacin Weaning vs Sudden Stopping in OAB
NCT04064619Completed
- Sponsor
- Beni Suef University
- Start
- Jan 2018
- Primary completion
- Aug 2019
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, open-label trial of solifenacin in overactive bladder (OAB) (2 arms), sponsored by Beni Suef University. Primary endpoint: Improvement of Condition at 1 month. Started Jan 2018; status: completed.
02
Drugs
solifenacin
03
Conditions
overactive bladder (OAB)
Beyond the preview
Go deeper on NCT04064619.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04064619.